Yonghua Huang Selected Research

troxerutin

3/2021	Neuroprotective effects of troxerutin and cerebroprotein hydrolysate injection on the neurovascular unit in a rat model of Middle cerebral artery occlusion.
12/2018	Troxerutin cerebroprotein hydrolysate injection ameliorates neurovascular injury induced by traumatic brain injury - via endothelial nitric oxide synthase pathway regulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yonghua Huang Research Topics

Disease

2	Cerebral Small Vessel Diseases 05/2024 - 01/2020
2	Neoplasms (Cancer) 01/2022 - 10/2019
2	Aneuploidy (Aneuploid) 01/2022 - 10/2019
2	Stroke (Strokes) 07/2020 - 01/2017
2	Ischemic Stroke 07/2020 - 05/2008
2	Cerebral Infarction 01/2015 - 05/2008
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023
1	Autistic Disorder (Autism) 06/2023
1	Coma (Comas) 04/2023
1	Reperfusion Injury 12/2021
1	Inflammation (Inflammations) 12/2021
1	Hypoxia (Hypoxemia) 12/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2021
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2021
1	Infarction (Infarctions) 03/2021
1	Cognitive Dysfunction 01/2019
1	Brain Edema (Cerebral Edema) 12/2018
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Seizures (Absence Seizure) 04/2017
1	Hypertension (High Blood Pressure) 11/2016
1	Leukoaraiosis 11/2016
1	Carotid Stenosis (Carotid Artery Stenosis) 11/2016
1	Coronary Disease (Coronary Heart Disease) 11/2016
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 10/2015
1	Transient Ischemic Attack 05/2008
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 04/2002

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 10/2019
2	Neuroprotective AgentsIBA 03/2021 - 01/2018
2	troxerutinIBA 03/2021 - 12/2018
2	HomocysteineIBA 11/2016 - 04/2002
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2023
1	LipopolysaccharidesIBA 06/2023
1	dichlorobis(azomycin)platinum IIIBA 01/2022
1	SolutionsIBA 01/2022
1	InflammasomesIBA 12/2021
1	GlucosidesIBA 12/2021
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 03/2021
1	Peroxynitrous Acid (Peroxynitrite)IBA 03/2021
1	Saline SolutionIBA 03/2021
1	cinepazideIBA 07/2020
1	Cytidine Diphosphate (CDP)IBA 10/2019
1	N-(4-isothiocyanatophenethyl)spiperoneIBA 10/2019
1	5,5-dimethyl-1,2,3-cyclohexanetrione 1,2-dioxime 3-thiosemicarbazoneIBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2017
1	Triglycerides (Triacylglycerol)IBA 11/2016
1	C-Reactive ProteinIBA 11/2016
1	Retinaldehyde (Retinal)IBA 11/2016
1	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 10/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2002
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2002

Therapy/Procedure

3	Therapeutics 12/2023 - 05/2008
2	Thrombolytic Therapy 01/2017 - 01/2015
1	Electrodes (Electrode) 04/2023
1	Injections 03/2021
1	Intraperitoneal Injections 03/2021
1	Activities of Daily Living (ADL) 07/2020
1	Intravenous Infusions 07/2020
1	Drug Therapy (Chemotherapy) 05/2008
1	Stents 05/2008
1	Carotid Endarterectomy 05/2008
1	Secondary Prevention 05/2008